June 2013 FDA Recall Sodium Chloride by Hospira Inc.
D-813-2013 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Hospira Inc. on June 27, 2013 for the product Sodium Chloride. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-813-2013

Reason for Recall
Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.
Initiated
06-27-2013
Reported
07-31-2013
Quantity
268,700 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide and Guam
Sodium Chloride Injection, USP, 0.9%, 20 mL Single-dose Fliptop Plastic Vial, packaged in 25 vial Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4888-20.

Batch or Lot Expiration Information

Lot# : 15-058-DK*, Exp 1MAR2014; note the * may be followed by 01